Agilent Technologies, Inc. vs Pfizer, Inc. — Stock Comparison
Agilent Technologies, Inc. (A) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Agilent Technologies, Inc. clearly outscores Pfizer, Inc. on Q·Score (7.8 vs 5.8 out of 10), led by Quality (8.5 vs 5) and Growth (8.3 vs 5.9). Pfizer, Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for A (+4.9%) than for PFE (+2.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.5× debt-to-equity).
Consistently beats earnings estimates (4/4 quarters).
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
A vs PFE: which stock scores better overall?
Based on Q·Score, Agilent Technologies, Inc. (A) scores 7.8/10 versus Pfizer, Inc. (PFE) at 5.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: A or PFE?
Agilent Technologies, Inc. (A) scores higher on Growth (8.3/10 vs 5.9/10). Agilent Technologies, Inc. reports revenue growth (10.0% YoY) while Pfizer, Inc. reports (2.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is A or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (5.9/10 vs 5.8/10). A trades at 23.2× P/E versus PFE at 9.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about A vs PFE?
There are 19 analysts covering A with a consensus price target of $160.89, and 26 analysts covering PFE with a consensus target of $28.61. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: A or PFE?
Agilent Technologies, Inc. (A) scores higher on Quality (8.5/10 vs 5/10). Net profit margin: A at 19.6%, PFE at 6.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: A or PFE?
Agilent Technologies, Inc. (A) scores higher on Financial Health (8.9/10 vs 7/10). Market beta: A at 1.23, PFE at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of A and PFE?
Agilent Technologies, Inc. (A) has a market capitalisation of $43.3B, while Pfizer, Inc. (PFE) has a market cap of $159.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do A or PFE pay dividends?
A pays a dividend yield of 0.66%, while PFE pays a dividend yield of 6.15%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →